Dark

Check out our API

EIDX
Eidos Therapeutics, Inc. Common Stock
stock NASDAQ

Inactive

Jan 25, 2021

122.21USD-4.851%(-6.23)335,508

Pre-market

0.00USD-100.000%(-128.44)0

After-hours

0.00USD0.000%(0.00)0

Overview HistoricalExchangesShortsNews

Jan 26, 2021

08:43AM EST BridgeBio Pharma Shares Move Higher; Co Announces Completion Of Merger With Eidos Therapeutics Benzinga

08:30AM EST BridgeBio Pharma, Inc. (BridgeBio) (Nasdaq: BBIO) today announced that it has completed its acquisition of all of the outstanding shares of Eidos Therapeutics, Inc. (Eidos) (formerly Nasdaq: EIDX) common stock that BridgeBio did not already own. The transaction was overwhelmingly approved by BridgeBio and Eidos stockholders. GlobeNewswire Inc

Jan 19, 2021

04:04PM EST Stockholders of BridgeBio Pharma and Eidos Therapeutics Approve BridgeBio Pharma Acquisition of Eidos Therapeutics Benzinga

04:01PM EST Stockholders of BridgeBio Pharma, Inc. and Eidos Therapeutics, Inc GlobeNewswire Inc

Jan 13, 2021

04:32PM EST BridgeBio Pharma And E Therapeutics Announce That The Acquisition Of Eidos Common Stock Not Held By BridgeBio As Mentioned In Previous Merger Agreement Is Set To Close On January 26th Benzinga

04:30PM EST BridgeBio Pharma, Inc. and Eidos Therapeutics, Inc. Announce GlobeNewswire Inc

Jan 6, 2021

04:54PM EST SHAREHOLDER ALERT: WeissLaw LLP Reminds EIDX, IPHI, ALXN, and XLNX Shareholders PR Newswire

Jan 5, 2021

11:26AM EST ALERT: Halper Sadeh LLP Investigates ALXN, SPWH, CBMG, STND, EIDX; Shareholders PR Newswire

08:39AM EST The Daily Biotech Pulse: Moderna Coronavirus Vaccine Receives Third Regulatory Nod, Gritstone Rallies On Hedge Fund Stake, aTyr's COVID-19 Drug Data Benzinga

Jan 4, 2021

11:42AM EST Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the board members of Eidos Therapeutics, Inc. (NASDAQ: EIDX) breached their fiduciary duties or violated the federal securities laws in connection with the companys merger BridgeBio Pharma, Inc. (NASDAQ: BBIO). GlobeNewswire Inc

07:30AM EST Leading Independent Proxy Advisory Firm ISS Recommends BridgeBio GlobeNewswire Inc

Dec 30, 2020

08:49PM EST WeissLaw LLP Reminds MTSC, EIDX, IPHI, and ALXN Shareholders About Its Ongoing PR Newswire

10:04AM EST Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: GlobeNewswire Inc

Dec 28, 2020

08:20PM EST SHAREHOLDER ALERT: Halper Sadeh LLP Investigates the Following Companies - PR Newswire

Dec 24, 2020

09:09AM EST Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: GlobeNewswire Inc

Dec 23, 2020

08:31AM EST The Daily Biotech Pulse: Supernus Issues Positive ADHD Readout, Sorrento Files For Emergency Use Authorization For Rapid COVID-19 Test, Inhibikase To Make Wall Street Debut Benzinga

Dec 19, 2020

04:17PM EST SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following PR Newswire

Dec 18, 2020

10:12PM EST SHAREHOLDER ALERT: WeissLaw LLP Reminds DMYD, EIDX, IPHI, and MCAC Shareholders PR Newswire

07:48AM EST The Daily Biotech Pulse: FDA Nod For Amgen's Biosimilar, Moderna's Vaccine Vote, Mesoblast Sinks On Data Benzinga

07:45AM EST The Daily Biotech Pulse: FDA Nod For Amgen's Biosimilar, Moderna's Vaccine Approved, Mesoblast Sinks On Data Benzinga

Dec 17, 2020

11:08PM EST Lifshitz Law Firm, P.C. Announces Investigation of ARA, BBIO, EIDX, CIT, EMIS, PR Newswire

Dec 16, 2020

01:15PM EST STOCKHOLDER ALERT: Monteverde & Associates Continues to Investigate the PR Newswire

Dec 15, 2020

07:52AM EST The Daily Biotech Pulse: Mesoblast Releases Mixed Data, MediWound Jumps On Distribution Deal, Kezar Life Sciences Rallies On Index Inclusion, Opiant Gets BARA Funding Benzinga

Dec 14, 2020

07:23AM EST 'Glaxo Bids $120 a Share for Eidos in Rival Offer' -Bloomberg, From Friday Benzinga

Dec 12, 2020

09:13AM EST Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: GlobeNewswire Inc

Dec 11, 2020

08:52PM EST WeissLaw LLP Reminds EIDX, IPHI, TGC, and APXT Shareholders About Its Ongoing PR Newswire

08:11AM EST The Daily Biotech Pulse: Pfizer-BioNTech Receive FDA Panel Backing, Sanofi-GSK Disclose Delay In Vaccine Program, 4 Biotechs To Debut On Wall Street Benzinga

Dec 10, 2020

07:42AM EST The Daily Biotech Pulse: Key Vaccine Adcom Review For Pfizer-BioNTech, Puma, Immutep, G1 Rally On Breast Cancer Conference Presentations Benzinga

Dec 8, 2020

08:04AM EST The Daily Biotech Pulse: ASH Presentations, Axsome's Positive Midstage Readout, Follow-On Offerings Benzinga

Dec 5, 2020

05:07AM EST Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following mergers: GlobeNewswire Inc

Dec 4, 2020

08:53PM EST WeissLaw LLP Reminds IPHI, EMIS, and EIDX Shareholders About Its Ongoing PR Newswire

11:48AM EST Merger Investigations; Investors are Encouraged to Contact the Firm - PNM, ELY, TNAV, NAV, EIDX PR Newswire

Dec 2, 2020

12:03PM EST SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of GlobeNewswire Inc

07:35AM EST The Daily Biotech Pulse: Pfizer-BioNTech Vaccine Gets Temporary UK Authorization, Ovid's Trial Disappointment, Vanda Snags FDA Nod Benzinga

Dec 1, 2020

08:08AM EST The Daily Biotech Pulse: Pfizer, BioNTech File Marketing Application In Europe, NuCana Jumps On Data, Amarin Takes On Hikma In Patent Lawsuit Benzinga

Nov 25, 2020

10:32PM EST Halper Sadeh LLP, a global investor rights law firm, announces it is investigating: GlobeNewswire Inc

08:01AM EST Lifshitz Law Firm, P.C. Announces Investigation of ARA, BBIO, BMCH, BLDR, CIT, PR Newswire

07:35AM EST The Daily Biotech Pulse: Revance's DAXI Regulatory Decision, Reata Slips On FDA Feedback, Liquidia Setback Benzinga

Nov 24, 2020

08:13AM EST The Daily Biotech Pulse: Alnylam's Oxluma Snags Early FDA Approval, DBV Chief Scientific Officer To Depart, Decision Day For Liquidia Benzinga

Nov 23, 2020

08:31PM EST WeissLaw LLP Reminds PTI, MVC, and EIDX Shareholders About Its Ongoing PR Newswire

Nov 20, 2020

09:34PM EST Halper Sadeh LLP, a global investor rights law firm, announces it is investigating: GlobeNewswire Inc

Nov 19, 2020

06:37PM EST SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of GlobeNewswire Inc

Nov 18, 2020

09:37AM EST Benzinga's Top Upgrades, Downgrades For November 18, 2020 Benzinga

06:05AM EST BTIG Downgrades Eidos Therapeutics to Neutral Benzinga

Nov 17, 2020

08:32AM EST The Daily Biotech Pulse: Setback For Alkermes, Boston Scientific's Recall, ALX-Zymeworks Oncology Collaboration Benzinga

Nov 13, 2020

10:35PM EST Halper Sadeh LLP, a global investor rights law firm, announces it is investigating: GlobeNewswire Inc

07:01PM EST SHAREHOLDER ALERT: WeissLaw LLP Reminds MVC, MOBL, GMHI, and EIDX Shareholders PR Newswire

12:30PM EST SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of GlobeNewswire Inc

07:40AM EST The Daily Biotech Pulse: Urovant In M&A Deal, Sanofi's Binary Event, Conference Presentations Benzinga

Nov 12, 2020

01:41PM EST Merger Investigations; Investors are Encouraged to Contact the Firm - GLIBA, VRTU, PRCP, WPX, EIDX PR Newswire

Nov 9, 2020

06:17PM EST SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigation of PR Newswire

Nov 7, 2020

07:49PM EST Halper Sadeh LLP, a global investor rights law firm, announces it is investigating: GlobeNewswire Inc

Nov 6, 2020

11:28PM EST SHAREHOLDER ALERT: WeissLaw LLP Reminds EIDX, GLIBA, and EV Shareholders About PR Newswire

08:01AM EST Holdings, Inc., BMC Stock Holdings, Inc., Callaway Golf Company, Cellular Biomedicine Group, Inc., CIT Group Inc., Eidos Therapeutics, Inc., Watford Holdings Ltd. and Yintech Investment Holdings Limited PR Newswire

07:47AM EST The Daily Biotech Pulse: Novartis Drug Flunks COVID-19 Study, Molecular Templates' Blood Cancer Study Placed On Partial Hold Benzinga

Nov 5, 2020

07:41AM EST BridgeBio Pharma Q3 EPS $(0.98) Down From $(0.51) YoY, Sales $8.13M Down From $26.74M YoY Benzinga

07:30AM EST -Merger agreement executed between BridgeBio and Eidos Therapeutics; Potential to bring BridgeBios clinical and commercial development infrastructure to bear upon Eidos Acoramidis GlobeNewswire Inc

Oct 31, 2020

06:57PM EDT Investigations; Investors are Encouraged to Contact the Firm - EIDX, RESI, PE, ARA PR Newswire

Oct 30, 2020

09:41PM EDT SHAREHOLDER ALERT: WeissLaw LLP Reminds VRTU, GLIBA, EV and EIDX Shareholders PR Newswire

03:31PM EDT Lifshitz Law Firm, P.C. Announces Investigation of Callaway Golf GlobeNewswire Inc

Oct 29, 2020

05:21PM EDT Eidos Therapeutics Q3 EPS $(0.79) Down From $0.18 YoY, Sales $127.00K Down From $26.69M YoY Benzinga

Oct 26, 2020

01:37PM EDT SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of GlobeNewswire Inc

Oct 23, 2020

04:44PM EDT Holdings, Inc., BMC Stock Holdings, Inc., Builders FirstSource, Inc., Cellular Biomedicine Group, Inc., CIT Group Inc., Eidos Therapeutics, Inc., MyoKardia, Inc. Watford Holdings Ltd. and Yintech Investment Holdings Limited PR Newswire

Oct 22, 2020

08:37PM EDT SHAREHOLDER ALERT: WeissLaw LLP Reminds MYOK, EIDX, GLIBA, and EV Shareholders PR Newswire

Oct 20, 2020

03:12PM EDT SHAREHOLDER ALERT: Halper Sadeh LLP is Investigating the Following Companies; PR Newswire

08:17AM EDT The Daily Biotech Pulse: Aptinyx Jumps On Positive Readout, Cara Executes Korsuva Licensing Deal, Cleveland BioLabs Rallies On Reverse Merger Benzinga

Oct 19, 2020

03:24PM EDT SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of GlobeNewswire Inc

Oct 15, 2020

04:23PM EDT SHAREHOLDER ALERT: WeissLaw LLP Reminds EIDX, REXN, and WPX Shareholders About PR Newswire

12:07PM EDT Lifshitz Law Firm, P.C. Announces Investigation of American Renal GlobeNewswire Inc

Oct 14, 2020

03:09PM EDT SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of PR Newswire

01:14PM EDT SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of GlobeNewswire Inc

Oct 9, 2020

06:23PM EDT EIDOS MERGER INVESTIGTION ALERT - Andrews & Springer LLC Is GlobeNewswire Inc

02:38PM EDT EIDOS THERAPEUTICS INVESTOR ALERT BY The Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Eidos Therapeutics, Inc. - EIDX Business Wire

11:19AM EDT SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of GlobeNewswire Inc

08:01AM EDT Holdings, Inc. (NYSE: ARA), BMC Stock Holdings, Inc., Builders FirstSource, Inc., Cancer Genetics, Inc., Cellular Biomedicine Group, Inc., Eidos Therapeutics, Inc., Montage Resources Corporation, MyoKardia, Inc. and Yintech Investment Holdings Limited PR Newswire

Oct 7, 2020

05:36PM EDT EIDX INVESTIGATION - Shareholder Rights Firm Labaton Sucharow is Investigating Eidos Therapeutics (NASDAQ: EIDX) for Potential Securities Violations and Breach of Fiduciary Duty Business Wire

09:02AM EDT Citigroup Downgrades Eidos Therapeutics to Neutral, Lowers Price Target to $73.26 Benzinga

08:56AM EDT EIDX INVESTIGATION - Shareholder Rights Firm Labaton Sucharow is Investigating Eidos Therapeutics (NASDAQ: EIDX) for Potential Securities Violations and Breach of Fiduciary Duty Business Wire

08:31AM EDT Therapeutics, Inc. (EIDX) and Encourages EIDX Shareholders to Contact the Firm PR Newswire

Oct 6, 2020

01:29PM EDT Moore Kuehn Encourages ARA, EIDX, MR, and MYOK Investors to Contact Law Firm PR Newswire

12:53PM EDT Following Mergers; Shareholders are Encouraged to Contact the Firm - MYOK, EIDX, PTI, GLIBA PR Newswire

10:14AM EDT Benzinga's Top Upgrades, Downgrades For October 6, 2020 Benzinga

06:43AM EDT BMO Capital Downgrades Eidos Therapeutics to Market Perform Benzinga

Oct 5, 2020

10:30PM EDT SHAREHOLDER ALERT: WeissLaw LLP Investigates Eidos Therapeutics, Inc. PR Newswire

09:00PM EDT SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation GlobeNewswire Inc

05:10PM EDT Eidos Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Eidos Therapeutics, Inc. is Fair to Shareholders; Investors Are Encouraged to Contact the Firm - EIDX Business Wire

02:39PM EDT Mid-Afternoon Market Update: Dow Surges 350 Points; Eidos Therapeutics Shares Spike Higher Benzinga

01:47PM EDT Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the board members of Eidos Therapeutics, Inc. (NASDAQ: EIDX) breached their fiduciary duties or violated the federal securities laws in connection with the companys merger with BridgeBio Pharma, Inc. (NASDAQ: BBIO). GlobeNewswire Inc

12:12PM EDT Mid-Day Market Update: Crude Oil Jumps 7%; Nam Tai Property Shares Plunge Benzinga

10:30AM EDT Mid-Morning Market Update: Markets Open Higher; Bristol-Myers Squibb To Acquire MyoKardia For $13B Benzinga

10:18AM EDT Shares of Eidos Therapeutics, Inc. (EIDX) are rising more than 34 percent or $18.06 in Monday's morning trade at $69.97, after touching a new 52-week high of $70.15. RTTNews

09:07AM EDT (EIDX) Alert: Johnson Fistel Investigates Proposed Sale of Eidos Therapeutics; PR Newswire

08:13AM EDT BridgeBio Pharma, Inc. (BBIO), a company focused on genetic diseases,announced Monday a definitive agreement to acquire around 36.3% stake in Eidos Therapeutics, Inc. (EIDX), a company focused on transthyretin or TTR amyloidosis or ATTR, that it does not already own. The deal has a value of up to an aggregate maximum of $175 million of cash. RTTNews

07:10AM EDT BridgeBio Agrees To Acquire All Outstanding Shares Of Eidos It Does Not Already Own RTTNews

07:06AM EDT BridgeBio Pharma and Eidos Therapeutics Announce Merger Agreement; Eidos Stockholders Will Have The Right To Receive In The Transaction, At Their Election, Either 1.85 Shares Of Bridgebio Common Stock Or $73.26 In Cash Per Eidos Share In The Transaction, Up To An Aggregate Maximum Of $175M Of Cash Benzinga

07:06AM EDT BridgeBio Pharma and Eidos Therapeutics Announce Merger Agreement; Eidos Stockholders Will Have The Right To Receive In The Transaction, At Their Election, Either 1.85 Shares Of Bridgebio Common Stock Or $73.26 In Cash Per Eidos Share In The Transaction Benzinga

07:04AM EDT BridgeBioto Acquire All Outstanding Shares of Eidos it Does Not Already Own GlobeNewswire Inc

Sep 22, 2020

09:36AM EDT Benzinga's Top Upgrades, Downgrades For September 22, 2020 Benzinga

07:10AM EDT Guggenheim Downgrades Eidos Therapeutics to Neutral Benzinga

Sep 8, 2020

10:10AM EDT Benzinga's Top Upgrades, Downgrades For September 8, 2020 Benzinga

06:19AM EDT Citigroup Initiates Coverage On Eidos Therapeutics with Buy Rating, Announces Price Target of $80 Benzinga

Aug 7, 2020

04:30PM EDT Eidos Therapeutics Appoints Industry Leaders With Significant GlobeNewswire Inc

Share